Veneman Ann M
Director at ALEXION PHARMACEUTICALS INC
- Sold, on record
- $1.7M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Sep 5, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ALEXION PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedFeb 17, 2012 2012
Sold 2,000 shares at $81.10 ($162k)
Veneman Ann M, Director
Sold 24.6% of holdings ($659k position)6,128 shares leftFirst sale on recordFiling
- 2 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualDec 12, 2012 +299 days
Sold 4,579 shares at $95.00 ($435k)
Veneman Ann M, Director
Sold 41.1% of holdings ($1.1M position)6,562 shares leftFiling
- 3 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualApr 29, 2013 +138 days
Sold 3,115 shares at $99.00 ($308k)
Veneman Ann M, Director
Sold 34.5% of holdings ($894k position)5,918 shares leftFiling
- 4 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedJun 4, 2014 +401 days
Sold 1,236 shares at $170.01 ($210k)
Veneman Ann M, Director
Sold 20.9% of holdings ($1M position)4,682 shares leftFiling
- 5 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualDec 11, 2014 +190 days
Sold 1,235 shares at $193.03 ($238k)
Veneman Ann M, Director
Sold 26.4% of holdings ($904k position)3,447 shares left0.4x usual sizeFiling
- 6 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedDec 11, 2015 +365 days
Sold 895 shares at $187.48 ($168k)
Veneman Ann M, Director
Sold 21.6% of holdings ($777k position)3,252 shares leftFiling
- 7 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedJul 31, 2017 +598 days
Sold 700 shares at $137.74 ($96k)
Veneman Ann M, Director
Sold 10% of holdings ($966k position)6,315 shares leftFiling
- 8 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedSep 5, 2017 +36 days
Sold 835 shares at $145.81 ($122k)
Veneman Ann M, Director
Sold 13.2% of holdings ($921k position)5,480 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2017 | Sep 5, 2017 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 835 | $122k | 13.2% | Plan not stated | SEC |
| Jul 31, 2017 | Aug 2, 2017 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 700 | $96k | 10.0% | Plan not stated | SEC |
| Dec 11, 2015 | Dec 15, 2015 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 895 | $168k | 21.6% | Plan not stated | SEC |
| Dec 11, 2014 | Dec 15, 2014 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 1,235 | $238k | 26.4% | Unusual | SEC |
| Jun 4, 2014 | Jun 6, 2014 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 1,236 | $210k | 20.9% | Plan not stated | SEC |
| Apr 29, 2013 | May 1, 2013 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 3,115 | $308k | 34.5% | Unusual | SEC |
| Dec 12, 2012 | Dec 14, 2012 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 4,579 | $435k | 41.1% | Unusual | SEC |
| Feb 17, 2012 | Feb 21, 2012 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 2,000 | $162k | 24.6% | Plan not stated | SEC |